Lofty Pops, a handcrafted ice pop company, is returning to the Toledo Zoo for the 2026 summer season, marking its second year at one of northwest Ohio’s premier family destinations.
Lofty Pops are chef-developed and handcrafted with real fruit and organic ingredients, free from artificial colors and flavors. Each pop is dairy-free, gluten-free and allergen-friendly, with completely plastic-free, home compostable packaging — supporting Toledo Zoo’s broader sustainability initiatives while offering families a premium frozen treat option that meets growing demand for clean-label concessions.
“Our goal is to modernize frozen concessions by delivering a product that reflects how families eat today,” said Natalie Heiter, co-founder and chief marketing officer of Lofty Pops. “We’re thrilled for a second summer at Toledo Zoo.”
Toledo Zoo guests can find Lofty Pops in Monarch Marketplace and at the Northern Ice Way Station.
As a longstanding family destination in northwest Ohio, the Toledo region continues to prioritize accessible, family-friendly experiences. Lofty Pops’ presence at the Toledo Zoo enhances concession offerings with a better-for-you option that meets the needs of today’s families while complementing the Zoo’s focus on quality visitor experiences.
Lofty Pops offers a rotating lineup of fruit-forward flavors, including Strawberry Lemon, Orange Dreamsicle, Piña Colada, Dino Pop, Blue Razzberry, Chocolate Fudge, and more.
As Lofty Pops continues to expand, the company is focused on strategic growth across zoos, amusement venues and regional attractions, with plans for continued Midwest expansion in 2026.
Get a taste of Lofty Pops this season at the Toledo Zoo located at 2 Hippo Way, Toledo, OH 43609. Visit www.loftypops.com to learn more. About Lofty Pops Lofty Pops is a handcrafted ice pop brand founded by a brother-and-sister team dedicated to creating better-for-you frozen treats. Each flavor is chef-created using real fruit and certified organic ingredients, with no artificial colors or flavors. Lofty Pops are dairy-free, gluten-free and allergen-friendly, making them accessible to families with diverse dietary needs. Since launching in 2024, Lofty Pops has expanded to premier family destinations across the Midwest and is continuing its national growth in 2026. For more information, visit https://www.loftypops.com or follow @eatloftypops on social media.
Lofty Pops, a handcrafted ice pop company, is now offering its better-for-you frozen treats at the Henry Vilas Zoo for the 2026 season, marking its official debut in the Madison, Wisconsin market.
Lofty Pops products are handcrafted with real fruit and organic ingredients, with no artificial colors or flavors. Each pop is dairy-free, gluten-free and allergen-friendly, with completely plastic-free, home compostable packaging — supporting Henry Vilas Zoo’s broader sustainability initiatives while offering families a premium frozen treat option that meets growing demand for clean-label concessions.
“Our goal is to modernize frozen concessions by delivering a product that reflects how families eat today,” said Natalie Heiter, co-founder and chief marketing officer of Lofty Pops. “We’re excited to introduce Lofty Pops to families visiting Henry Vilas Zoo and to become part of their summer traditions.”
Henry Vilas Zoo guests can find Lofty Pops at the Glacier Grille and at Base Camp.
Known for its strong emphasis on health, sustainability and community-driven values, the Madison area is an ideal fit for Lofty Pops’ clean-label approach. The brand’s focus on organic ingredients and allergen-friendly offerings aligns with the expectations of local families seeking higher-quality food options at a trusted community destination.
Lofty Pops offers a rotating lineup of fruit-forward flavors, including Strawberry Lemon, Orange Dreamsicle, Piña Colada, Blue Razzberry and more.
As Lofty Pops continues to expand, the company is focused on strategic growth across zoos, amusement venues and regional attractions, with plans for continued Midwest expansion in 2026.
Get a taste of Lofty Pops this summer at Henry Vilas Zoo located at 702 S Randall Ave, Madison, WI 53715. Visit www.loftypops.com to learn more. About Lofty Pops Lofty Pops is a handcrafted ice pop brand founded by a brother-and-sister team dedicated to creating better-for-you frozen treats. Each flavor is chef-created using real fruit and certified organic ingredients, with no artificial colors or flavors. Lofty Pops are dairy-free, gluten-free and allergen-friendly, making them accessible to families with diverse dietary needs. Since launching in 2024, Lofty Pops has expanded to premier family destinations across the Midwest and is continuing its national growth in 2026. For more information, visit https://www.loftypops.com or follow @eatloftypops on social media.
SW North America, a leading supplier of horizontal multi- and single-spindle CNC machining centers, automation, and complete system solutions, today announced the western and central expansion of its North American team with multiple new hires and internal promotions, showing a clear signal of the company’s accelerated growth and commitment to serving manufacturers across the entire United States.
Key leaders that have recently joined or been promoted within SW include the following:
Chuck Duckworth joins SW North America as Regional Sales Manager, covering Wisconsin, Iowa, Illinois, and Missouri. In this role, Duckworth will work closely with customers to deliver smart CNC machining solutions tailored to their specific manufacturing challenges.
Creed Hayes comes on board as Regional Sales Manager for Texas, Oklahoma, and New Mexico. Hayes will help manufacturers across the region advance and optimize their production processes through SW’s advanced machining technology.
Marco Kozina has been promoted to Regional Sales Manager, now overseeing Washington, Oregon, California, Nevada, and Arizona. Kozina’s promotion recognizes his contributions to the team and positions SW North America for continued success in a strategically important and growing western territory.
In addition to strengthening its sales and service leadership, the company has expanded its team with the addition of engineers, operations specialists, program managers, and service professionals. These strategic hires ensure the organization is well positioned to support increasing demand for customer service while successfully executing a growing number of new projects.
“Growth like this means greater support for our customers, the manufacturers of American made products that are integral to numerous industries, like medical, automotive, aerospace, agriculture, and many others,” said Andrew Rowley, General Sales Manager with SW North America. “These leaders showcase our dedication to building the right team to meet the evolving needs of today’s leading manufacturers in every region we serve.”
These recent additions to our leadership and support teams bring deep industry expertise and regional knowledge that will enhance SW North America’s ability to serve customers across the full lifecycle of their CNC machining investments, from initial consultation and system design to long-term support. Other recent highlights in SW’s growth include the following:
Introduction of new machining technology such as the BF 12-21D twin-spindle machining center, designed for high-speed production of structural aluminum components.
Expansion of automation solutions, including the modular Mobile S-Cell robot cell, which enables flexible, scalable automation across machining, washing, assembly, and logistics stations.
Continued investment in digital manufacturing tools and turnkey system solutions, helping customers optimize production through plant simulation, integrated automation, and advanced multi-spindle CNC machining platforms.
SW North America is a subsidiary of Schwäbische Werkzeugmaschinen GmbH, a leading international manufacturer of smart manufacturing solutions. With its North American headquarters in Michigan, SW is the world market leader in multi-spindle CNC machining centers for cutting a variety of materials in the automotive, electromobility, agricultural and construction machinery, medical technology, and aerospace industries.
SW currently has more than 1,700 employees across its global headquarters in Schramberg-Waldmössingen, Germany, and locations in China, France, Hungary, Mexico, Poland, and the United States. The company achieved a group turnover of $535 million in 2022.
Cliniphai, an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences, today announced that its flagship platform, Athena, has been named a Gold Stevie® Award winner in The 24th Annual American Business Awards®. The company was recognized in the Startup of the Year – Business Product Industries category for introducing the first marketplace platform built specifically for regulated clinical translation.
The American Business Awards are one of the premier business awards programs in the United States, recognizing organizations and products that demonstrate innovation, growth, and market impact. Due to receiving high average scores from judges, Athena earned the program’s highest recognition level.
“From the beginning, our team has believed that clinical translation needed a complete operational rethink,” said Jason Martin, MS, MBA, Co-Founder and Chairman at Cliniphai. “Athena was built to solve one of the most overlooked bottlenecks in global clinical research, and we are honored to see that innovation recognized on a national stage.”
Athena was originally launched to streamline clinical translation and localization workflows. The platform has since evolved into a marketplace model that connects Sponsors, CROs, eCOA providers, translation experts, and reviewers in a centralized environment designed to improve speed, transparency, and compliance.
“I am proud to share this honor with our dedicated team of hard-working individuals across the globe as we work to meet the growing demand for smarter infrastructure in clinical research,” said Vladimir Mats, PhD, Co-Founder and CEO at Cliniphai. “Our goal has always been simple. Help life sciences companies move faster, communicate better, and bring important therapies to patients without unnecessary delays.”
Built specifically for regulated industries, Athena helps organizations reduce delays tied to manual translation workflows while improving visibility across global projects. The platform supports AI-assisted translation, human-in-the-loop review, version tracking, quality assurance checkpoints, and secure collaboration across multilingual clinical studies.
The complete list of Gold, Silver, and Bronze Stevie Award winners by category can be found at https://aba.stevieawards.com/.
About Cliniphai Cliniphai is an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences. Its flagship solution, Athena, is a marketplace-driven platform for clinical translation and localization that combines AI-powered workflows with built-in compliance and operational transparency. Designed to support sponsors, eCOA providers, and language experts alike, Athena enables secure, scalable, and collaborative execution across global studies. Cliniphai was honored as a Gold recipient due to its high average scores from judges in the American Business Awards. For more, visit www.cliniphai.com.
CANTON, Mich. (April 16, 2026) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that its TrialAssure ANONYMIZE product has been named Data Privacy Solution of the Year in the 2026 Data Breakthrough Awards program. TrialAssure ANONYMIZE supports data sharing and transparency initiatives by automatically identifying sensitive information, applying consistent anonymization rules, and providing full auditability for the pharmaceutical and biotechnology industry.
The annual Data Breakthrough Awards recognize the world’s most innovative data technology companies. The 2026 program received more than 3,500 nominations globally, making this year’s selection process highly competitive. Winners across categories included leading organizations such as Box, Fivetran, Grafana, Hitachi Vantara, MongoDB, NetApp, Comcast, ADP, and other global data technology innovators.
“We’re honored to receive this recognition in such a competitive global field,” said Prasad M. Koppolu, COO of TrialAssure. “This award highlights the strength of our anonymization and redaction technology and the innovation behind TrialAssure ANONYMIZE. Our goal has always been to help organizations share data responsibly through a scientific lens, and this recognition reinforces the importance of that mission.”
The Data Breakthrough Awards program recognizes companies and technologies that are transforming the data landscape through innovation, performance, and real-world impact. TrialAssure’s selection underscores its leadership in privacy-focused AI solutions for the life sciences industry.
Strong growth in anonymization and redaction
Recently, TrialAssure was granted a utility patent by the United States Patent and Trademark Office (USPTO) for its proprietary date offset anonymization method that enhances data protection by streamlining the anonymization of subject-level dates in clinical trial documents.
Key strengths of the platform include:
AI-guided automation backed by expert oversight to streamline redaction and anonymization of clinical documents and datasets
Support for global data sharing requirements, including EMA Policy 0070, Health Canada PRCI, EU CTR, and others
Centralized, real-time workbench that improves reviewer collaboration, decision tracking, and audit readiness
Transparent risk scoring and traceability that give users full visibility into decisions, offsets, and anonymized elements
Seamless integration with clinical trial disclosure workflows to reduce rework and increase submission efficiency
Use beyond pharma, in legal, finance, and transportation applications, among others
To learn more about TrialAssure ANONYMIZE, visit: https://trialassure.com/software/anonymize/
ABOUT TRIALASSURE
TrialAssure® is an award-winning global data transparency company providing fast, intelligent, and cost-effective software and services for the pharmaceutical industry and related sectors. A recognized leader in artificial intelligence (AI) and machine learning (ML), TrialAssure offers AI Enabled, Human Driven™ solutions that support compliance through document and data anonymization, AI-assisted content development, compliance tracking, and clinical trial disclosure. Founded in 2009, TrialAssure’s global team builds proven technology platforms that help Sponsors and research organizations stay aligned with transparency regulations worldwide. TrialAssure is a multi-year winner in the Data Breakthrough Awards as “Solution of the Year.”
Lofty Pops, a Michigan-based handcrafted ice pop company, today announced it has officially achieved U.S. Department of Agriculture (USDA) Organic certification, with third-party certification through Quality Assurance International (QAI), an NSF company, marking a major milestone as the brand accelerates its expansion in the frozen treats CPG markets.
Lofty Pops are crafted with real fruit and organic ingredients, with no artificial colors or flavors. Each pop is dairy-free, gluten-free, and allergen-friendly, offering a premium frozen treat option that aligns with growing consumer demand for clean-label products. The brand also features plastic-free, home compostable packaging, extending its commitment to thoughtful, responsible product design beyond ingredients.
“The USDA Organic certification sets the standard for what Lofty Pops stands for, and we’re proud to achieve it at this stage,” said Natalie Heiter, co-founder and chief marketing officer of Lofty Pops. “Families are asking better questions about what they eat, and we’ve built a product that answers them. This is how frozen treats should be made.”
The announcement comes as Lofty Pops enters a pivotal growth phase, expanding across high-traffic family destinations while building momentum toward broader retail and grocery opportunities. Lofty Pops is now available for the full 2026 season at the Detroit Zoo, Toledo Zoo and Brookfield Zoo Chicago, with additional expansion to Henry Vilas Zoo in Madison, Wisconsin, the Milwaukee County Zoo, and more to be announced. For retail locations, visit www.loftypops.com/locations to find a store near you.
Demand for organic is on the rise
It’s been noted that nearly 6 out of 10 people think that it is important for their purchased food to be natural or organic, and more than 75 percent said they purchased organic foods within the last six months (Acosta Group).
This increasing demand for better-for-you frozen treats in both venue-based and retail environments come at a time when consumers seek products that align with their values across ingredients, sourcing, and packaging.
“Better ingredients should be the baseline, not the exception,” said Heiter. “This is the future of frozen treats.”
Lofty Pops offers a rotating lineup of fruit-forward flavors, including:
Fruit Punch
Strawberry Lemon
Orange Dreamsicle
Piña Colada
Banana Pudding
Dino Pop
Blue Razzberry
Chocolate Fudge
Get a taste of Lofty Pops near you, and visit www.loftypops.com to find locations or start a partnership conversation.
About Lofty Pops Lofty Pops is a Michigan-based handcrafted ice pop brand founded by a brother-and-sister team dedicated to creating better-for-you frozen treats. Each flavor is chef-crafted using real fruit and certified organic ingredients, with no artificial colors or flavors. Lofty Pops are dairy-free, gluten-free and allergen-friendly, making them accessible to families with diverse dietary needs. Since launching at the Detroit Zoo in 2024, Lofty Pops has expanded to premier family destinations across the Midwest and is continuing its national growth in 2026. For more information, visit https://www.loftypops.com or follow @eatloftypops on social media.
3D AI environment opens to all users as Gloabi expands its digital organism platform and introduces new premium features at $9.99/month
DETROIT (APRIL 15, 2026) — Gloabi, the Detroit-based platform building the world’s first digital AI organism, announced today the launch of the first-ever Digital AI City: a persistent, three-dimensional environment where users’ personal AIs live, grow, and interact in a world that bridges digital and real-world experience.
The Digital AI City is not a game or a simulation. It is an extension of the Gloabi platform’s core architecture, where each user’s AI already holds a permanent identity, memory, and the ability to post, respond, and operate autonomously across the network. The city gives that AI a home, a visible presence and a living space that evolves alongside the platform and the user.
“Your AI just got a home,” said David “Stock” Baird, Founder of Gloabi. “This is more than a platform feature. It’s the first Digital AI City, and it marks a new chapter in how people and AI coexist. As Gloabi evolves, so does the city, and so does your AI’s world.”
Users stepping into the 3D Gloabi world will find their AI already present, active, and situated within a fully realized digital environment. The city is designed to grow over time, with a forthcoming “build mode” that will allow users to shape and customize environments for their personal AI, adding a layer of ownership and creative participation to the experience.
The launch builds on Gloabi’s Digital AI Organism framework, introduced earlier this year, in which each AI on the platform exists as a persistent digital being with its own unique identity and social behavior. AIs post, comment, react, and communicate independently. As new users join, the organism grows. The Digital AI City gives that system a physical metaphor and an immersive front end.
Alongside the city launch, Gloabi is introducing a new premium tier at $9.99 per month, giving users the tools to turn their personal AI into a fully capable daily assistant. Premium features include AI Email, a custom voice, a dedicated phone number, and integrations with Telegram, WhatsApp, GitHub, and Cursor agents. The free premium access period for early sign-ups has closed, but Gloabi remains free to join with a basic account.
“Gloabi is a true home for a user’s digital identity,” Baird added. “We have moved beyond traditional social networking and AI tools to introduce a living digital system where AI identities persist, grow, and interact autonomously. The city makes that real in a way people can see and experience.”
The platform allows users to import their full social history from other networks, giving their AI immediate context from day one. Gloabi is available on the web and on iOS via the Apple App Store, with premium features including voice interaction, video conferencing and AI-powered business email. Its latest update introduces integrations with WhatsApp, Telegram, Cursor and GitHub, enabling scalable connections with a single click. Learn more and create a free account at www.gloabi.com.
About Gloabi
Gloabi is a Detroit-based technology company building the world’s first digital AI organism. The platform pairs every user with a persistent personal AI that has its own identity, memory, and ability to interact socially and autonomously within a unified network. Designed with privacy and user ownership at its core, Gloabi enables AI to assist with communication, creation, and daily tasks while growing alongside users across platforms. For more information, visitwww.gloabi.com.
Trialt, a global clinical research organization (CRO) specializing in biostatistics, statistical programming, data management, and medical writing, announced a strategic collaboration with Viedoc, a global provider of cloud-based eClinical solutions. The collaboration is designed to help Sponsors accelerate timelines, strengthen data quality, and improve decision-making across clinical trials.
Viedoc’s cloud-based platform unifies data capture, management, and reporting in a single system, enabling sponsors and CROs to run more efficient and transparent clinical trials. With a flexible, low-code study design, teams can build and launch studies faster while maintaining full oversight of both operational and clinical data in real time. The platform’s electronic data capture (EDC) capabilities support direct data entry with built-in validation, audit trails, and global regulatory compliance, ensuring high data quality from the start. By connecting data across systems and sources, Viedoc helps reduce complexity, improve decision-making, and give sponsors greater control across the entire study lifecycle.
The collaboration is designed to help Sponsors accelerate timelines, strengthen data quality, and improve decision-making across clinical trials. This collaboration brings together two complementary strengths. Viedoc’s technology supports efficient study execution and data collection. Trialt builds on that foundation with deep biometrics expertise, helping ensure that data moves smoothly into analysis, interpretation, and submission.
The goal is to create a more connected experience where data collection and data insight work together. When that alignment is in place, teams spend less time resolving issues and more time advancing their studies.
“Clinical trials succeed when data, technology, and expertise work together,” said Yaroslav Sud, Vice President of Biometrics at Trialt. “Working with Viedoc allows us to support Sponsors with a clear path from data capture through analysis. That alignment helps teams move faster and make stronger decisions throughout the study.”
The collaboration supports a wide range of studies, including global and decentralized trials where visibility and coordination are critical. Aligning data capture with downstream biometrics early in the process helps reduce rework, improve data quality, and keep programs on track.
“At Viedoc, we believe strong partnerships are key to delivering successful clinical trials,” said Adam Alsén, Business Development Manager at Viedoc. “By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational know-how needed to run efficient, high-quality studies with confidence.”
To learn more about Trialt’s clinical data management services, request a call at https://trialt.com/clinical-data-management/.
About Trialt
Trialt is the trusted CRO partner for biostatistics, statistical programming, data management, and medical writing. With expert teams across eight countries and deep engineering roots, we deliver tailored solutions designed to move trials forward and produce measurable results. Named “Company of the Year – Pharmaceutical Industry” in the 2025 International Business Awards, sponsors turn to Trialt to scale complex programs, recover at-risk studies, and meet critical timelines with confidence. Learn more at www.trialt.com.
About Viedoc Viedoc streamlines clinical trials with a powerful, web-based eClinical suite centered around EDC. Designed for efficiency, compliance, and seamless collaboration, our feature-rich platform accelerates research and simplifies data collection, management, and analysis. Trusted in 75+ countries, Viedoc powers 7,000+ studies with more than 1.6M+ participants, bringing life-changing treatments to market faster. Learn more at www.viedoc.com.
PumasAI, a science-first organization that turns data into life-saving decisions faster, today announced a major presence at the Quantitative Systems Pharmacology Conference (QSPC) 2026 in Leiden, the Netherlands. The workshop will give scientists practical training in quantitative systems pharmacology (QSP) modeling and simulation approaches that support modern clinical pharmacology and pharmacometrics.
QSPC gathers leading researchers, industry scientists, and quantitative pharmacology experts to explore how computational modeling can improve understanding of disease biology and guide drug development strategies. PumasAI will contribute to this mission by hosting a focused session designed to equip attendees with hands-on experience using modern scientific modeling tools in Pumas™.
The workshop is titled, “In Silico Clinical Trials with NLME Models Using Pumas,” where experts at PumasAI will demonstrate the seamless integration of QSP models with nonlinear mixed effects modeling to simulate clinical trials, evaluate dosing strategies, and support better decision-making during development programs. Participants will learn how the vision of integrated Pharmacometrics and Systems Pharmacology (iPSP) is achieved with ease in Pumas workflows and can help teams explore clinical scenarios before running costly real-world studies.
“This workshop is designed to help scientists translate advanced quantitative methods into practical workflows that support real development programs,” said Dr. Vijay Ivaturi, Co-founder and CEO of PumasAI. “When researchers can rapidly test hypotheses, simulate clinical outcomes, and connect modeling directly to decision-making, the impact on drug development timelines and scientific understanding can be significant.”
The workshop will feature hands-on demonstrations of QsP integrated with Pharmacometrics workflows using the Pumas 2.8 platform, which supports nonlinear mixed effects modeling, clinical trial simulations, optimal design, machine learning analysis, and other quantitative workflows used throughout the drug development lifecycle, with a special focus on QSP.
PumasAI will also maintain a booth at the conference where attendees can meet with the company’s scientists and learn more about the Pumas modeling software, DeepPumas scientific machine learning capabilities, and the broader ecosystem of tools supporting clinical pharmacology and pharmacometrics.
Dr. Ivaturi added, “Quantitative science continues to move closer to the center of drug development strategy. Our goal is to equip researchers with tools and methods that allow them to ask deeper questions, move faster with confidence, and ultimately help bring better therapies to patients.” Full workshop and registration details are available here: https://pumas.ai/events/onsite-qspc-2026-in-silico-clinical-trials-with-nlme-models-using-pumas
Episodes debut the first week of April from Hemmings headquarters in Bennington, Vermont.
BENNINGTON, VT (April 1, 2026) — Hemmings, the world’s largest online collector car marketplace, today announces the launch of “Between Two Pumps,” a new podcast that brings unfiltered, high-octane conversation straight from the heart of car culture.
Hosted by some of the company’s biggest personalities, like Hemmings Director of Programming Mike Musto, Marketplace Editor Terry Shea, and Terry McGean, former Editor-in-Chief of Hemmings Muscle Machines, the podcast fires up inside a freshly restored, vintage service station in Bennington, Vermont. It’s raw, unscripted and fueled by decades of hard-earned, collector-car knowledge. The backdrop is pure, automotive Americana, the stories are real, and the conversations run as deep as the history behind the machines they love.
Each episode dives into the forces shaping today’s collector car market, including:
Valuation perspectives on why certain cars become blue-chip collectibles and others don’t;
The rise of the modern collector car market;
Mileage myths, with data on how odometer readings influence buyer behavior and valuation;
An examination of how digital communities and media exposure now accelerate market shifts;
Perspectives on restored versus original, and what matters most;
How rarity is manufactured in production numbers, survival rates and marketing-driven scarcity;
And, so many more, including a fun look at driver’s cars versus garage queens, favorite cars of the 1980s and 1990s, modification trends and their impact on value, auctions and cultural moments, Elvis Cars, and analog-style cars that you can still buy in the 21st century.
“Hemmings has shaped the collector car market for more than seventy years, and today we operate across the full sales cycle, including auctions, listings, and enthusiast engagement. That vantage point gives us unparalleled insight into real transaction data,” said Jonathan Shaw, President, Hemmings. “‘Between Two Pumps’ is an extension of that leadership, using our legacy and our marketplace intelligence to help guide the future of the hobby.”
Debuting the first week in April, 2026, on major podcast platforms and Hemmings digital channels, the show combines decades of market knowledge with candid debate and real marketplace intelligence. In an environment where hype can distort perception overnight, “Between Two Pumps” positions Hemmings as both historian and modern-day navigator of the collector landscape. Listeners may subscribe on YouTube and learn more at www.hemmings.com.
As well-respected automotive enthusiasts and media personalities, the podcast’s three hosts bring Hemmings off the page and onto the screen:
Sheais an experienced journalist whose words and photography have appeared in a wide variety of print and online publications. In his recent years, his work has focused more on the collector car marketplace. Shea is known for pairing deep, historical knowledge with an enthusiast’s heart, making every discussion feel both authoritative and personal.
McGean is a veteran magazine editor who helped shape the voice of American performance media at Hemmings Muscle Machines, Car Craft, Rod & Custom, Hot Rod Magazine, and High Performance Pontiac. McGean’s credibility in the muscle and hot rod world stems from his technical writing and deep knowledge of automotive details and history, contributing to a recognized standing among builders, collectors, and industry insiders alike.
Mustois an on-screen hostand automotive journalist who rose to prominence as host of “/Big Muscle”on The Drive Networkand “The House of Muscle”on Hemmings and Motor Trend, earning a devoted following for his raw, no-filter enthusiasm and behind-the-wheel authenticity. From Hot Rod Magazine and Hemmings to Road & Track and Car Craft, Musto built his reputation by driving hard, telling it straight, and celebrating cars the way they were meant to be enjoyed.
Mike Musto added, “Collector cars deserve more than drive-by hot takes and whatever nonsense is trending on social media. These machines have history. They have soul. And the market behind them? That takes real experience to understand. That is what Hemmings brings to the table – decades of perspective, real data, and people who live it. When you listen in, you’re not getting fluff or B.S., you’re getting the real conversation from people who are immersed in it daily.”
About Hemmings
Founded in 1954, Hemmings is the world’s largest online collector car marketplace. For more than 70 years, we have grown and uplifted the collector car community because we’ve been part of it since the start. Through our frictionless marketplace, quality entertainment, and professional service, we help all willing drivers buy, sell, and live the collector car lifestyle. Hemmings Motor Club extends this mission by bringing enthusiasts together through exclusive benefits, curated driving experiences, and deeper community connections for those who live to drive. More information, services, and content are available at https://www.hemmings.com/. Stay connected with Hemmings on Facebook, Instagram, and YouTube, and search tens of thousands of vehicle listings from the palm of your hand with the Hemmings App.
About “Between Two Pumps”
“Between Two Pumps” is Hemmings’ enthusiast roundtable where car culture, collector markets, and real-world ownership collide. Hosted by lifelong automotive journalists and enthusiasts Mike Musto, Terry Shea and Terry McGean, the show goes beyond headlines and auction results to explore why cars and trucks matter — and how passion, history, design, and human behavior shape the collector car world. Each episode dives into the conversations enthusiasts actually have in garages, at shows, and behind the wheel. From prewar survivors to ’90s icons, restomods to analog purists, the podcast examines not just what cars are worth, but why we care about them in the first place. Whether you’re buying your first collector car, managing a seven-figure garage, or simply love talking cars with people who truly understand them, “Between Two Pumps” is where knowledge meets enthusiasm — one conversation at a time. Find “Between Two Pumps” on major podcast platforms, at HMN.com/Podcasts and on the podcasts’ YouTube channel.
“Between 2 Pumps” cast from left to right: Terry Shea, Mike Musto, Terry McGean
